Sunday, August 14, 2022

Australian biotech firm CSL completes the acquisition of Vifor Pharma AG

0
CSL Limited is pleased to announce it has now received all necessary regulatory clearances for the acquisition of Vifor Pharma AG (Vifor) initially announced on 14 December 2021. CSL has set the settlement date of the public tender offer for Vifor for 9 August 2022. If the offer conditions that remain in effect until the settlement remain fulfilled until that date, shareholders who accepted the offer will receive the offer price for each share tendered into the offer on the settlement date, subject to the terms of the offer. CSL anticipates that it will hold more than 97% of Vifor Pharma AG shares upon the settlement of the offer and intends to have Vifor apply for the delisting of the Vifor Pharma AG Shares after the settlement.

Australians need to prepare for the brewing CO-Flu storm this winter

0
As Australia heads towards winter, workplaces could be facing the perfect storm: the ongoing threat of COVID-19 converging with seasonal influenza. Not only can these illnesses wreak havoc on people’s health, but they can severely impact businesses. We’re all aware of the wide-spread risks of Covid-19, but one study has found that employees who come to work sick cost employers two to three times as much in productivity losses than employees who stay home. And while some businesses may have shifted to operating remotely, unplanned employee absences due to illness can derail project timelines.

INVL Baltic Sea Growth Fund to buy a modern Baltics care treatment centre

0
INVL Baltic Sea Growth Fund (the Fund), a private equity investment fund in the Baltic region, has announced that it has signed an agreement to acquire one of the most modern medical treatment centres in the Baltic region, located in Birštonas, Nemunas as well as the largest rehabilitation and post-acute care treatment centres in the Baltics, Eglės Sanatorija.

Vape manufacturer SMOORE opens first PMTA testing laboratory in China

0
SMOORE, a vape manufacturer, announced that is has opened China’s first non-clinical full-scale testing laboratory for Premarket Tobacco Product Applications (PMTA). A PMTA is an application that must be reviewed and approved by the Food and Drug Administration (FDA) before a new nicotine product can be legally marketed in the US. It must also provide scientific data that demonstrates a product is appropriate for the protection of public health.

Who Let The Doc Out?! #020: What you need to know about calories, energy...

0
Many people attach a negative connotation to calories, automatically correlating them with excess weight gain, but they are in fact extremely important for the normal functioning of the human body.

Mind Blank’s Ally Kelly receives award for her suicide prevention initiatives

0
Ally Kelly has been awarded with the Outstanding Achievement Award, which is presented by Suicide Prevention Australia as part of the LiFE awards 2021.

Who Let The Doc Out?! #018: What your poop says about your health

0
Pooping is one of those things that everyone does, but no one really wants to talk about. However, more of us should be talking about it, because your poop can tell you and your doctor a whole lot about your health, from the number of times you poop, to the way your poop looks in the toilet.

How to help colleagues and staff struggling with mental health issues

0
There are signs and resources are available to help colleagues tackle these challenges and support someone close to you who may be struggling with their mental health.

Black Dog Institute offers tips to stay well while working in trying times

0
As we start 2022 facing new, albeit not entirely unfamiliar, uncertainties that affect all aspects of our lives, it is more important than ever to consider the toll placed on our wellbeing by these factors and the implications for our mental health in terms of our working lives.

Three out of four Australians believe their posture needs improvement

0
Upright by DarioHealth, a global company in connected posture management, conducted research in 2021 on Aussies' attitude towards their posture and found that 3/4 of Australians believe their posture needs improvement. The survey revealed that Australians have noticed a deterioration in their posture over the past two years, with 41% of participants reporting that they have experienced a back health issue as a result of working from home.